Insights

Insights

Filter by:
Governing Laws
Sector Life sciences & healthcare
Sub-sector
Service
Sub-service
Hot Topics Coronavirus
blueprints
Synapse

Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?

22 April 2020
IN-DEPTH ANALYSIS

by Dr. Anja Lunze, LL.M. and Dr. Jan Phillip Rektorschek

Click here to find out more
Life sciences & healthcare

Termination, force majeure and frustration – international perspectives on the life sciences sector

17 April 2020
QUICK READ

by multiple authors

Click here to find out more
Patents & innovation

COVID-19 and public compulsory licensing of drugs in Europe

17 April 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more
pipette
Synapse

COVID-19 and life sciences M&A

16 April 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more
Patents & innovation

Marketing authorisation and clinical testing of new drugs

15 April 2020

by Dr. Anja Lunze, LL.M. and Dr. Jan Phillip Rektorschek

Click here to find out more
Patents & innovation

Restrictions for patents owners to preserve the public interest in the sufficient availability of necessary medicinal products

7 April 2020

by Dr. Anja Lunze, LL.M. and Dr. Jan Phillip Rektorschek

Click here to find out more
scientist
Synapse

COVID-19: healthcare and law

31 March 2020
IN-DEPTH ANALYSIS

by Barbora Dubanská, LL.M., MHA, Ph.D. and Patrick Boháček

Click here to find out more
Product liability & product safety

Personal protective equipment COVID-19 export restrictions

23 March 2020
QUICK READ

by Katie Chandler and Tasmina Goraya, PhD

Click here to find out more